Obstacles to affordable cancer treatments.
Recent regulatory and policy changes may help to improve the affordability of some high-cost cancer treatments. However, larger systemic changes are needed to address the excessive growth in spending for cancer therapies and to ensure that patients and payers receive maximum value for their health care dollars.